首页> 外文会议>Reporters, markers, dyes, nanoparticles, and molecular probes for biomedical applications II >Transferrin protein nanospheres: a nanoplatform for receptor-mediated cancer cell labeling and gene delivery
【24h】

Transferrin protein nanospheres: a nanoplatform for receptor-mediated cancer cell labeling and gene delivery

机译:转铁蛋白蛋白质纳米球:用于受体介导的癌细胞标记和基因传递的纳米平台

获取原文
获取原文并翻译 | 示例

摘要

This paper presents preliminary results on the use of transferrin protein nanospheres (TfpNS) for targeting cancer cells in vitro. Protein nanospheres represent an easily prepared and modifiable nanoplatform for receptor-specific targeting, molecular imaging and gene delivery. Rhodamine B isothiocyanate conjugated TfpNS (RBITC-TfpNS) show significantly enhanced uptake in vitro in SK-MEL-28 human malignant melanoma cells known to overexpress transferrin receptors compared to controls. RBITC-TfpNS labeling of the cancer cells is due to transferrin receptor-mediated uptake, as demonstrated by competitive inhibition with native transferrin. Initial fluorescence microscopy studies indicate GFP plasmid can be transfected into melanoma cells via GFP plasmid encapsulated by TfpNS.
机译:本文介绍了转铁蛋白纳米球(TfpNS)用于体外靶向癌细胞的初步结果。蛋白质纳米球代表了易于制备且可修饰的纳米平台,用于受体特异性靶向,分子成像和基因传递。罗丹明B异硫氰酸酯缀合的TfpNS(RBITC-TfpNS)在已知与对照相比过表达运铁蛋白受体的SK-MEL-28人恶性黑色素瘤细胞中显示出显着增强的体外摄取。癌细胞的RBITC-TfpNS标记归因于运铁蛋白受体介导的摄取,如天然运铁蛋白的竞争性抑制所证明。最初的荧光显微镜研究表明,GFP质粒可以通过TfpNS封装的GFP质粒转染到黑色素瘤细胞中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号